Scientists hunt for clues to HIV remission without daily pills
NCT ID NCT07692295
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study brings together data from multiple previous trials to investigate a rare group of people with HIV who can keep the virus under control even after stopping antiretroviral therapy. Researchers will analyze stored blood samples and clinical records to look for biological markers that predict this sustained viral control. The goal is to better understand what allows some individuals to maintain HIV remission without ongoing medication, which could inform future cure strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify biological markers that predict which people with HIV can safely stop antiretroviral therapy without the virus rebounding.
- What could go wrong
- This is an observational study that analyzes existing data, not a treatment trial. It may not find clear biomarkers, and any findings would need further validation in future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Choice may boost HIV prevention: a trial tests offering multiple PrEP options to young women in kenya
- Home care plus nutrition may cut post-hospital deaths in HIV — a trial puts it to the test
- Heavy drinking and risky sex: a text-based intervention aims to cut HIV risk
- Pharmacists on the front line: a new strategy to fight heart disease in people with HIV
- Early HIV treatment may shield immune cells from lasting damage